Plasma concentration of atorvastatin metabolites correlates with low‐density lipoprotein cholesterol reduction in patients with coronary heart disease

Plasma concentration of atorvastatin metabolites correlates with low‐density lipoprotein cholesterol reduction in patients with coronary heart disease

Abstract In this exploratory study from a randomized double‐blinded crossover trial including 70 patients with coronary heart disease and self‐perceived muscular side effects of statins, we aimed to determine the relationship between low‐density lipoprotein cholesterol (LDL‐C) reduction and atorvast...

Full description

Bibliographic Details
Main Authors: E. Sverre, J. Munkhaugen, O. Kristiansen, H. Weedon‐Fekjær, K. Peersen, E. Gjertsen, L. Gullestad, S. Bergan, E. Husebye, N. T. Vethe
Format: Article
Language:English
Published: Wiley 2023-06-01
Series:Pharmacology Research & Perspectives
Subjects:
adherence
atorvastatin
coronary heart disease
LDL‐cholesterol
liquid chromatography‐tandem mass spectrometry
Online Access:https://doi.org/10.1002/prp2.1089

Internet

https://doi.org/10.1002/prp2.1089

Similar Items